Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 49
Gene Symbol: ACR
ACR
0.010 GeneticVariation group BEFREE Male patients on the other hand presented more often with serositis (p = 0.0003), renal disorder (p < 0.0001), and immunologic disorder (p = 0.04) by the ACR definitions. 31843005 2019
Entrez Id: 23205
Gene Symbol: ACSBG1
ACSBG1
0.010 Biomarker group BEFREE 106 primary ITP patients (16 with newly-diagnosed ITP, 16 with persistent ITP and 74 with chronic ITP) and 39 secondary ITP patients (20 with ITP secondary to immune disorders, 7 with ITP secondary to infectious diseases and 12 with ITP secondary to lymphoproliferative disorders [LPD]) were retrospectively evaluated. 31840311 2020
Entrez Id: 65059
Gene Symbol: RAPH1
RAPH1
0.010 Biomarker group BEFREE 106 primary ITP patients (16 with newly-diagnosed ITP, 16 with persistent ITP and 74 with chronic ITP) and 39 secondary ITP patients (20 with ITP secondary to immune disorders, 7 with ITP secondary to infectious diseases and 12 with ITP secondary to lymphoproliferative disorders [LPD]) were retrospectively evaluated. 31840311 2020
Entrez Id: 11092
Gene Symbol: SPACA9
SPACA9
0.010 GeneticVariation group BEFREE These are oxytocin receptor desensitization and downregulation as factors during labor in offspring autism development; reductions in the oxytocin receptor numbers in the fixed oxytocin receptor expression that occurs before birth; MAST Immune System disease; and the excess number of dendritic spines from lack of pruning observed in brains of autistic people. 31827587 2019
Entrez Id: 51324
Gene Symbol: SPG21
SPG21
0.010 GeneticVariation group BEFREE These are oxytocin receptor desensitization and downregulation as factors during labor in offspring autism development; reductions in the oxytocin receptor numbers in the fixed oxytocin receptor expression that occurs before birth; MAST Immune System disease; and the excess number of dendritic spines from lack of pruning observed in brains of autistic people. 31827587 2019
Entrez Id: 5021
Gene Symbol: OXTR
OXTR
0.010 AlteredExpression group BEFREE These are oxytocin receptor desensitization and downregulation as factors during labor in offspring autism development; reductions in the oxytocin receptor numbers in the fixed oxytocin receptor expression that occurs before birth; MAST Immune System disease; and the excess number of dendritic spines from lack of pruning observed in brains of autistic people. 31827587 2019
Entrez Id: 84166
Gene Symbol: NLRC5
NLRC5
0.010 AlteredExpression group BEFREE However, the evidence for higher expression of NLRC5 in immune disease still remains controversial. 31824312 2019
Entrez Id: 975
Gene Symbol: CD81
CD81
0.010 Biomarker group BEFREE Previous work found that anti-CD81 monoclonal antibodies (mAbs) showed therapeutic potential for several immune diseases via inhibiting leukocyte migration. 31794019 2020
Entrez Id: 3558
Gene Symbol: IL2
IL2
0.070 Biomarker group BEFREE Moreover, stimulation of PD-1 with specific agonists, perhaps in combination with low-dose IL-2, could be an effective therapeutic strategy in autoimmune disease and in other immune disorders. 31781109 2019
Entrez Id: 339896
Gene Symbol: GADL1
GADL1
0.010 GeneticVariation group BEFREE These findings suggest that rs17026688 polymorphisms in GADL1 are associated with immune dysfunction in BDI patients. 31767892 2019
Entrez Id: 2697
Gene Symbol: GJA1
GJA1
0.010 Biomarker group BEFREE Targeting Cx43 could be developed to treat certain antibody-related immune diseases. 31752090 2019
Entrez Id: 1234
Gene Symbol: CCR5
CCR5
0.020 GeneticVariation group BEFREE A 32-base pair deletion (∆32) in the open reading frame (ORF) of C-C motif chemokine receptor 5 (CCR5) seems to be a protective variant against immune system diseases, especially human immunodeficiency virus type 1 (HIV-1). 31730458 2019
Entrez Id: 940
Gene Symbol: CD28
CD28
0.030 Biomarker group BEFREE In recent years, increasingly attention has been paid to CD28, which is considered as a key therapeutic target for many modern diseases, especially some immune diseases. 31729942 2019
Entrez Id: 23135
Gene Symbol: KDM6B
KDM6B
0.010 Biomarker group BEFREE The Jumonji domain-containing protein D3 (JMJD3), specifically demethylate di- and trimethyl-lysine 27 on histone H3 (H3K27me2/3), has been widely studied in immune diseases, infectious diseases, cancer, developmental diseases, and aging related diseases. 31701394 2019
Entrez Id: 953
Gene Symbol: ENTPD1
ENTPD1
0.020 Biomarker group BEFREE Modulation of CD39 and exogenous APT102 correct immune dysfunction in experimental colitis and Crohn's disease. 31693091 2019
Entrez Id: 10318
Gene Symbol: TNIP1
TNIP1
0.110 Biomarker group BEFREE Although TNIP1 and the TNF-α/NF-κB axis play key roles in immune diseases and inflammatory responses, their relationship and role in glioma remain unknown. 31691497 2020
Entrez Id: 50943
Gene Symbol: FOXP3
FOXP3
0.100 Biomarker group BEFREE Understanding Foxp3 protein features and modulation mechanisms may help in the design of rational therapies for immune diseases and cancer. 31681337 2019
Entrez Id: 3458
Gene Symbol: IFNG
IFNG
0.070 GeneticVariation group BEFREE Symptoms in CFA-challenged IFN-γ KO resemble systemic juvenile idiopathic arthritis (sJIA), a childhood immune disorder of unknown cause. 31676671 2019
Entrez Id: 50943
Gene Symbol: FOXP3
FOXP3
0.100 AlteredExpression group BEFREE The results indicate that CDK8/19 is physiologically repressing Foxp3 expression in activated conventional T cells and that its pharmacological inhibition enables conversion of antigen-specific effector/memory T cells into Foxp3<sup>+</sup> T<sub>reg</sub> cells for the treatment of various immunological diseases. 31653719 2019
Entrez Id: 1024
Gene Symbol: CDK8
CDK8
0.010 AlteredExpression group BEFREE The results indicate that CDK8/19 is physiologically repressing Foxp3 expression in activated conventional T cells and that its pharmacological inhibition enables conversion of antigen-specific effector/memory T cells into Foxp3<sup>+</sup> T<sub>reg</sub> cells for the treatment of various immunological diseases. 31653719 2019
Entrez Id: 7172
Gene Symbol: TPMT
TPMT
0.020 GeneticVariation group BEFREE TPMT and NUDT15 polymorphisms are major determinants of tolerance to thiopurine drugs used in leukemias and nonmalignant immunologic disorders. 31651720 2020
Entrez Id: 55270
Gene Symbol: NUDT15
NUDT15
0.010 GeneticVariation group BEFREE TPMT and NUDT15 polymorphisms are major determinants of tolerance to thiopurine drugs used in leukemias and nonmalignant immunologic disorders. 31651720 2020
Entrez Id: 2261
Gene Symbol: FGFR3
FGFR3
0.010 Biomarker group BEFREE Autoantibodies directed against TS-HDS and FGFR-3 suggest an immune disorder in otherwise idiopathic SFN. 31650561 2020
Entrez Id: 79947
Gene Symbol: DHDDS
DHDDS
0.010 Biomarker group BEFREE Autoantibodies directed against TS-HDS and FGFR-3 suggest an immune disorder in otherwise idiopathic SFN. 31650561 2020
Entrez Id: 9619
Gene Symbol: ABCG1
ABCG1
0.010 Biomarker group BEFREE In conclusion, this study showed that PNE could suppress Tregs development in female mice by up-regulating ABCG1-dependent cholesterol efflux, and suggested that PNE-induced thymic Tregs recession of offspring at early life was the developmental origin mechanism of immune dysfunction in later life. 31629012 2019